Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mark Quinn, Paul Ellis, Anita Pye & Alice M Turner. (2020) Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives. Therapeutics and Clinical Risk Management 16, pages 1243-1255.
Read now
Read now
Priya S Chukowry, Ross Gareth Edgar & Alice M Turner. (2019) Alpha 1 antitrypsin deficiency: a rare multisystem disease, predominantly affecting the lung. Expert Opinion on Orphan Drugs 7:7-8, pages 315-326.
Read now
Read now
Ilaria Ferrarotti, Angelo Guido Corsico, Jan Stolk, Stefania Ottaviani, Marco Fumagalli, Sabina Janciauskiene & Paolo Iadarola. (2017) Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:1, pages 56-65.
Read now
Read now
Robert A. Stockley. (2015) Antitrypsin Deficiency Assessment and Programme for Treatment (ADAPT): The United Kingdom Registry. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:sup1, pages 63-68.
Read now
Read now
Dippica Mistry & Robert A. Stockley. (2010) Gamma-Glutamyl Transferase: The Silent Partner?. COPD: Journal of Chronic Obstructive Pulmonary Disease 7:4, pages 285-290.
Read now
Read now
Articles from other publishers (9)
Linxi Meng, Will Treem, Graham A. Heap & Jingjing Chen. (2022) A stacking ensemble machine learning model to predict alpha-1 antitrypsin deficiency-associated liver disease clinical outcomes based on UK Biobank data. Scientific Reports 12:1.
Crossref
Crossref
Franck F. Rahaghi. (2021) Alpha-1 antitrypsin deficiency research and emerging treatment strategies: what’s down the road?. Therapeutic Advances in Chronic Disease 12_suppl, pages 204062232110140.
Crossref
Crossref
María Torres-Durán, José Luis Lopez-Campos, Miriam Barrecheguren, Marc Miravitlles, Beatriz Martinez-Delgado, Silvia Castillo, Amparo Escribano, Adolfo Baloira, María Mercedes Navarro-Garcia, Daniel Pellicer, Lucía Bañuls, María Magallón, Francisco Casas & Francisco Dasí. (2018) Alpha-1 antitrypsin deficiency: outstanding questions and future directions. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
S. A. Townsend, R. G. Edgar, P. R. Ellis, D. Kantas, P. N. Newsome & A. M. Turner. (2018) Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease. Alimentary Pharmacology & Therapeutics 47:7, pages 877-885.
Crossref
Crossref
NALAN OGAN, sezen baglan UZUNGET & Berkay EKİCİ. (2017) Kronik Obstrüktif Akciğer Hastalığının Akut Alevlenmesi ile Nötrofil-Lenfosit Oranı ve Serum Ürik Asit Düzeyleri Arasındaki İlişki. TURKISH JOURNAL of CLINICS and LABORATORY.
Crossref
Crossref
N. A. Shaposhnikova, I. S. Shuliat'ev & G. G. Varvanina. (2015) Clinical and prognostic value of deficiency an alpha-1-antitrypsin at patients with chronic diseases of a liver. Laboratornaya sluzhba 4:2, pages 16.
Crossref
Crossref
Kazunori Morita, Natsuki Masuda, Takahiro Tanaka, Junji Saruwatari, Kentaro Oniki, Ayami Kajiwara, Koji Otake, Yasuhiro Ogata & Kazuko Nakagawa. (2015) A functional variant in the γ-glutamyltransferase (GGT)1 gene is associated with airflow obstruction in smokers. Clinical Chemistry and Laboratory Medicine (CCLM) 53:12.
Crossref
Crossref
Robert A. Stockley & Alice M. Turner. (2014) α-1-Antitrypsin deficiency: clinical variability, assessment, and treatment. Trends in Molecular Medicine 20:2, pages 105-115.
Crossref
Crossref
James E. Everhart & Elizabeth C. Wright. (2013) Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV). Hepatology 57:5, pages 1725-1733.
Crossref
Crossref